(Q48286778)

10 February 2018

title

Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. (English)

1 reference

10 February 2018

0 references

0 references

0 references

8

1 reference

10 February 2018

Tiziana Rubino

object named as

Tiziana Rubino

7

0 references

Daniela Parolaro

9

object named as

Daniela Parolaro

1 reference

10 February 2018

author name string

Cinzia Guidali

1

1 reference

10 February 2018

Daniela Viganò

2

1 reference

10 February 2018

Stefania Petrosino

3

1 reference

10 February 2018

Erica Zamberletti

4

1 reference

10 February 2018

Natalia Realini

5

1 reference

10 February 2018

Giorgio Binelli

6

1 reference

10 February 2018

publication date

3 March 2010

1 reference

10 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

10 February 2018

volume

14

1 reference

10 February 2018

page(s)

17-28

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

Behavioural despair in rats: A new model sensitive to antidepressant treatments

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Outcome of a first episode of psychosis in adolescence: a 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Endocannabinoid signalling in the blood of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Activation of c-fos in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Hippocampal modulation of sensorimotor processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Molecular targets for treating cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Tactile experience induces c-fos expression in rat barrel cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Clinical complexity and person-centered integrative diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

7 January 2021

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

7 January 2021

A rapid method for the regional dissection of the rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

7 January 2021

Phencyclidine-induced expression of c-Fos-like immunoreactivity in mouse brain regions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

7 January 2021

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

7 January 2021

Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000209

7 January 2021

10.1017/S1461145710000209

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

20196921

1 reference

10 February 2018